WASHINGTON, Jan 17 (Reuters) - U.S. Health and Human

Services Secretary Xavier Becerra said on Friday the government

will try to negotiate better prices for the 15 drugs targeted

for Medicare price negotiations for 2027 because they are too

expensive.

"The reason we're going to negotiate for lower prices of

these 15 drugs, the way we did last year for the 10 most

expensive drugs, is because the facts show that not only do they

work, but those drugs are too expensive and should be lowered in

price," Becerra said in an interview with CNN.